Hirai, J.; Mori, N.; Hanai, Y.; Asai, N.; Hagihara, M.; Mikamo, H.
Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan. Antibiotics 2025, 14, 228.
https://doi.org/10.3390/antibiotics14030228
AMA Style
Hirai J, Mori N, Hanai Y, Asai N, Hagihara M, Mikamo H.
Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan. Antibiotics. 2025; 14(3):228.
https://doi.org/10.3390/antibiotics14030228
Chicago/Turabian Style
Hirai, Jun, Nobuaki Mori, Yuki Hanai, Nobuhiro Asai, Mao Hagihara, and Hiroshige Mikamo.
2025. "Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan" Antibiotics 14, no. 3: 228.
https://doi.org/10.3390/antibiotics14030228
APA Style
Hirai, J., Mori, N., Hanai, Y., Asai, N., Hagihara, M., & Mikamo, H.
(2025). Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan. Antibiotics, 14(3), 228.
https://doi.org/10.3390/antibiotics14030228
